Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.
about
Kynurenine is an endothelium-derived relaxing factor produced during inflammationThe physiological action of picolinic Acid in the human brainInflammation in depression: is adiposity a cause?Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisQuinolinic acid, the inescapable neurotoxinKynurenines in the mammalian brain: when physiology meets pathologyEmerging roles of pericytes in the regulation of the neurovascular unit in health and diseaseInflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injuryHuman α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD): a structural and mechanistic unveilingKynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depressionEating ourselves to death (and despair): the contribution of adiposity and inflammation to depressionThe kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.Early activation of the kynurenine pathway predicts early death and long-term outcome in patients resuscitated from out-of-hospital cardiac arrestThe involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/-) mice, using liquid chromatography-tandem mass spectrometry.The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*.Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection.Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms.The kynurenine pathway in stem cell biology.The common inflammatory etiology of depression and cognitive impairment: a therapeutic target.The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities.Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic AcidThe kynurenine pathway and the brain: Challenges, controversies and promises.Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis.The role of tryptophan metabolism in postpartum depression.Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1.Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.
P2860
Q24630488-E8F58B24-3CB4-4190-A2F4-EB52B4392436Q24634995-6662E528-FEF7-4535-8F1B-AF895DF93C1CQ24635451-20FD6E22-2E19-414B-90A7-1DB161539E9DQ26740330-BBAF9A38-6A08-48BF-AFA4-BB47824C7913Q26991715-0AB80983-4AC2-4A73-BDE5-F448C8F06795Q27003296-DD22E406-37F4-478F-9250-C3B9F2072055Q27011505-B2AC6726-F1ED-4087-BA7E-1A351AAA0403Q27310505-FD314705-6E39-4BCB-A073-1D5CF233A41FQ28115413-3DD90538-A0EA-464D-A987-72C4CB04ADA7Q33572850-0A6911F6-1A7B-474C-BC0F-C0DA92958D93Q33751166-35244243-1AB5-4966-85CF-22AB54F79A8AQ34090453-56D618C3-BFCF-4A3B-AB44-151FB2E7ED48Q34248380-B6A1B592-9D57-477F-8E7D-A90E46E7840EQ34997869-8A918E35-CBB3-4F91-8FD9-950152FB6983Q35026406-B7255A72-9805-453E-AC44-389D4E107420Q35029070-153FAB80-4602-4FA8-984D-06D30D72F602Q35156136-3A7E2DFA-8CEA-4C18-B8BE-A54789BA9224Q35366778-7E272D31-60D0-4E6C-87C6-0398CA0E25E5Q36131465-BCC99245-8081-4D5D-9849-0074BEB5A158Q36763697-6276411F-CC95-435A-83A7-AD782CCDF018Q36865674-2A3CBB02-05F0-49B5-B202-53DC65AE9599Q37318862-F388AE2B-7CF7-4657-BA99-93AC308ED38EQ37726311-FCA4FD20-1F39-49D4-BA1C-A54AE56E5137Q37813804-32C39E9E-3459-4345-B830-B209CD0434D5Q37992617-B56C0D98-8CB3-425E-AA32-0A0AE80645E3Q38149123-374334AE-49FD-4962-A358-D545CEC0E892Q38245307-2E304A83-E864-48F0-8653-75239217333FQ38675915-7D760EC9-4D71-423D-A5B3-680B2D825CC7Q38729027-24D4F07B-98DD-4138-822C-DEC5FC18184AQ38832497-D7C9659A-BE96-4BCE-85AD-9F0EEFC736CEQ39616472-FA7C11A0-4419-4232-AFCD-3A8F2289D422Q47201558-2C896AA6-79C6-4D8E-A3A6-AD8B68C80AF0Q50532036-C1826C13-4C7D-46C5-BED6-0BC01683FA3AQ52725478-EBEA7F16-BAEE-4BBE-A318-EF21C5D3A5B8Q55381445-D6D936C6-3DE9-451F-B5D7-A31CCAF86BCE
P2860
Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.
@en
Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.
@nl
type
label
Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.
@en
Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.
@nl
prefLabel
Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.
@en
Kynurenine pathway metabolism ...... e tolerance and neurotoxicity.
@nl
P2093
P2860
P1476
Kynurenine pathway metabolism ...... ne tolerance and neurotoxicity
@en
P2093
David Walker
George Smythe
Muhammad Mukhtar
Nicole L Webster
Patricia J Armati
Robert Owe-Young
Roger J Pomerantz
Suzanne M Crowe
P2860
P304
P356
10.1111/J.1471-4159.2008.05241.X
P407
P50
P577
2008-01-21T00:00:00Z